NeuroOne Medical Technologies (NMTC) Stock Price
NeuroOne Medical Technologies Price
Revenue has compounded at 85.2% per year over the past 15 years to 12.10 M USD. NeuroOne Medical Technologies's net margin stands at -29.8%, up from -5,584.3% several years earlier. Analysts set a median price target of 2.35 USD, implying 134.6% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.
NeuroOne Medical Technologies stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
NeuroOne Medical Technologies business model & stock analysis
Frequently asked questions about NeuroOne Medical Technologies
Analysts currently set an average price target of 2.35 USD for the NeuroOne Medical Technologies stock (median: 2.35 USD), implying +134.6 % versus the latest price. The consensus is based on 8 analyst ratings.
9 analysts currently rate the NeuroOne Medical Technologies stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect NeuroOne Medical Technologies to generate revenue of 9.54 M USD and earnings per share of -4.43 USD.
Converted at the current exchange rate, the NeuroOne Medical Technologies share trades at 0.89 EUR (1.00 USD).
The NeuroOne Medical Technologies share (NMTC) is listed on 1 stock exchanges, including: NASDAQ (NMTC).
The expected revenue of NeuroOne Medical Technologies is 9.54 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of NeuroOne Medical Technologies is -37.15 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of NeuroOne Medical Technologies is currently -0.23. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the NeuroOne Medical Technologies stock.
The price-to-sales ratio (P/S) of NeuroOne Medical Technologies is currently 0.88. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the NeuroOne Medical Technologies stock.
The Eulerpool Quality Score for NeuroOne Medical Technologies is 3/10.
The ISIN of NeuroOne Medical Technologies is US64130M2098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of NeuroOne Medical Technologies is NMTC. The ticker symbol is used to trade NeuroOne Medical Technologies shares on the stock exchange.
NeuroOne Medical Technologies stock
NeuroOne Medical Technologies Peer Group
NeuroOne Medical Technologies Ticker
NeuroOne Medical Technologies FIGI
All fundamentals and in-depth analysis of NeuroOne Medical Technologies
Our stock analysis for NeuroOne Medical Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NeuroOne Medical Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.